Biocartis Raises EUR10 Million in Series A Financing Round
15th October 2009 LAUSANNE, Switzerland, October 15 /PRNewswire/ -- Biocartis SA, a diagnostics company focused on fast and low-cost,
integrated molecular and immunodiagnostics based on its...
Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners
12th October 2009 CAMBRIDGE, England, October 12 /PRNewswire/ -- Crescendo Biologics ("Crescendo") today announces it has
raised GBP4.5 million in a seed-funding round to advance the development of
its fragment...
BMEYE B.V. Completes EUR 6 Million Series B Financing Round
8th October 2009 AMSTERDAM, October 8 /PRNewswire/ -- BMEYE B.V., the non-invasive cardiovascular monitoring
company, today announced the successful completion of its Series B financing
round, raising EUR 6 million....
Assist America Sponsors the Bedouin Heritage Project
7th October 2009 PRINCETON, New Jersey, October 7 /PRNewswire/ -- Assist America, Princeton, N.J., U.S.A., is pleased to announce its
sponsorship of the Bedouin Heritage Project, an organization dedicated...
Accumetrics Announces US$16.5M in New Capital Financing
6th October 2009 SAN DIEGO, October 6 /PRNewswire/ -- Accumetrics, Inc., developer and marketer of the VerifyNow(R) System, the
first rapid and easy-to-use diagnostic system for measuring an individual's
response to...
Bicycle Therapeutics Ltd, a New Medical Research Council (MRC) Spin-out, Seeking to Merge Best Aspects of Small Molecules and Biologics, Secures Seed Funding From Top Venture Capital Firms
6th October 2009 LONDON, October 6 /PRNewswire/ -- Bicycle Therapeutics Ltd, a new biotechnology company
developing a novel technology platform for the creation of a new generation
of biotherapeutics, has secured...
Neopharma Expands Into Biotechnology and Nanotechnology-Based Research and Development
6th October 2009 DUBAI, UAE, October 6 /PRNewswire/ -- Neopharma, the Abu Dhabi-based pharmaceuticals manufacturer,
has ventured into biotechnology and nanotechnology-based research and
manufacturing capabilities.
...
Elsevier Launches SciVal Funding Solution to Help U.S. Research Institutions Better Compete for Grants
28th September 2009 AMSTERDAM, September 28 /PRNewswire/ -- Elsevier, a world-leading publisher of scientific, technical and medical
information products and services, today announced the launch of SciVal
Funding, a...
Agendia Raises US $23 Million in Series E Financing
22nd September 2009 HUNTINGTON BEACH, California and AMSTERDAM, September 22 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced
the successful closing of a US $23 million series E...
ProFibrix Raises US $11 Million (EUR 8 Million) in Series B Financing
24th August 2009 LEIDEN, The Netherlands and SEATTLE, August 24 /PRNewswire/ -- ProFibrix B.V., a leader in the development of innovative
products for hemostasis and regenerative medicine, today announced...
AdvanDx Closes US$8 Million Financing Round and Elects New Board Member
18th August 2009 WOBURN, Massachusetts and VEDBAEK, Denmark, August 18 /PRNewswire/ -- AdvanDx today announced it has closed another US$8 million in financing
from existing stockholders, SLS Venture and LD Pensions....
Altacor Beats Biotech Funding Drought
13th August 2009 CAMBRIDGE, England, August 13 /PRNewswire/ -- Ophthalmology development and marketing company Altacor has announced
closing of a GBP1m first tranche of Series B funding. The round was led by
two new...
CTMM Becomes One of the World's Largest Public-Private Partnerships in Translational Medical Research
4th August 2009 EINDHOVEN, The Netherlands, August 4 /PRNewswire/ -- With today's final approval of a research project into prostate cancer,
the Dutch CTMM (Center for Translational Molecular Medicine) today...
Long-term Investment Secured - Swiss Foundation Supports Innovative Concept for Patients With Diabetes
3rd July 2009 Z
Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals
29th June 2009 UPPSALA, Sweden, June 29 /PRNewswire/ -- Gyros AB, the leading provider of automated micro-immunoassays for
therapeutic protein development, announces that it has raised SEK 80 million
(approximately...
Clavis Pharma Raises NOK 129 Million (USD 20 Million) in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug Candidates
26th June 2009 OSLO, Norway, June 26 /PRNewswire/ -- Clavis Pharma ASA (OSE: CLAVIS) today announced that the
Company has raised NOK 129 million (equivalent to USD 20 million) in gross
proceeds through a private...
Cappella Inc. Secures US$17.3 Million Series C Investment
15th June 2009 WILMINGTON, Delaware and GALWAY, Ireland, June 15 /PRNewswire/ --
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
